Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
about
Tracking Cefoperazone/Sulbactam Resistance Development In vivo in A. baumannii Isolated from a Patient with Hospital-Acquired Pneumonia by Whole-Genome SequencingRetrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality
P2860
Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Pharmacokinetics of cefoperazo ...... ous venovenous hemofiltration.
@en
Pharmacokinetics of cefoperazo ...... ous venovenous hemofiltration.
@nl
type
label
Pharmacokinetics of cefoperazo ...... ous venovenous hemofiltration.
@en
Pharmacokinetics of cefoperazo ...... ous venovenous hemofiltration.
@nl
prefLabel
Pharmacokinetics of cefoperazo ...... ous venovenous hemofiltration.
@en
Pharmacokinetics of cefoperazo ...... ous venovenous hemofiltration.
@nl
P2093
P2860
P1476
Pharmacokinetics of cefoperazo ...... ous venovenous hemofiltration.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00228-016-2045-X
P577
2016-03-29T00:00:00Z